☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Cidara Therapeutics
Cidara Therapeutics Receives European Approval for Rezzayo to Treat Invasive Candidiasis
December 26, 2023
Cidara Therapeutics & Mundipharma received a Positive opinion from the EU’s CHMP for Rezzayo (Rezafungin) to Treat Invasive Candid...
October 13, 2023
Insights+: The US FDA New Drug Approvals in March 2023
April 19, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.